First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis.

Name: First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis.
Author: Holleman, Marscha S

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis. — المؤلف: Holleman, Marscha S — OncoTargets and therapy 2019

المؤلف: Holleman, Marscha S
النشر: OncoTargets and therapy 2019
الوصف: 1413-1421 p.